Register for our free email digests:
Division of Valeant Pharmaceuticals International Inc.
Latest From Aridis Pharmaceuticals LLC
The World Health Organisation has released a list of 12 bacteria it says pose the greatest threat to human health as a way of urging governments and the drug development industry to incentivize and launch an R&D response against the increasing global issue of antibiotic resistance.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
- Antisense, Oligonucleotides
- Large Molecule
- Therapeutic Areas
- OSI Eyetech
- Eyetech Pharmaceuticals Inc.
- North America
- Parent & Subsidiaries
- Valeant Pharmaceuticals International Inc.
- Senior Management
- Steve Bettis, Pres.
- Contact Info
Phone: (919) 325-2788
11360 Jog Road
Palm Beach Gardens, FL 33418
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.